Acer Therapeutics Inc.

The momentum for this stock is not very good. Acer Therapeutics Inc. is not a good value stock. Acer Therapeutics Inc. is not a good growth stock. Acer Therapeutics Inc. is not very popular among insiders. Acer Therapeutics Inc. is a mediocre stock to choose.

Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development,...

News

Acer Therapeutics announces ISS, Glass Lewis recommended 'FOR' proposed merger

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Acer Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related Proposals

Globe Newswire Acer Shareholders Please Vote Today!NEWTON, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and...\n more…

Hunter Associates Investment Management LLC Increases Stock Position in Acer Therapeutics Inc. (NASDAQ:ACER)

Ticker Report Hunter Associates Investment Management LLC raised its position in Acer Therapeutics Inc. (NASDAQ:ACER Free Report) by 215.8% during the second quarter, according to its most recent...\n more…

Acer Therapeutics Inc. (NASDAQ:ACER) Sees Large Decline in Short Interest

Zolmax Acer Therapeutics Inc. (NASDAQ:ACER Get Free Report) was the recipient of a significant drop in short interest during the month of September. As of September 30th, there was short interest...\n more…

Acer Therapeutics Inc. (NASDAQ:ACER) Short Interest Update

Zolmax Acer Therapeutics Inc. (NASDAQ:ACER Get Free Report) saw a large increase in short interest during the month of September. As of September 15th, there was short interest totalling 898,100...\n more…

Acer Therapeutics (NASDAQ:ACER) Stock Crosses Below Two Hundred Day Moving Average of $0.87

Zolmax Acer Therapeutics Inc. (NASDAQ:ACER Get Free Report)s stock price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.87...\n more…